View Partner Button
Picture of researcher

Cancer Clinical Trials

Site: Thorax/Chest

The most recent listing of current clinical trials for thorax and chest cancers — including lung, esophagus and thymoma — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
 

Site: Thorax/Chest
(Includes Lung, Esophagus and Thymoma)

Protocol ID    Title

MAGRIT 109493    Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer

Keywords: Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer

1199.14    Multicenter, randomized, double-blind, Phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy

Keywords: stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy

RTOG 0915    A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer

Keywords: Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer

RTOG 0813    Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients

Keywords: Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients

In-House    Management of Respiratory Organ Motion in Radiation Therapy (Thorax, Abdomen, Breast, Pelvis)

Keywords: radiation therapy

RTOG 0617
NCCTG N0628
CALGB 30609
   A Randomized Phase III Comparison of Standard-Dose (60 Gy) vs. High Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/ Paclitaxel in Patients with Stage IIIA/ IIIB Non-Small Cell Lung Cancer

Keywords: Stage IIIA/ IIIB Non-Small Cell Lung Cancer

RTOG 0618    A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer

Keywords: Operable Stage I/II Non-Small Cell Lung Cancer

CALGB 30610/ RTOG 0538    Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

Keywords: Limited Small Cell Lung Cancer

Memorial Sloan Kettering
(also in GI)
   A Random Assignment Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) versus Parent DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma

Keywords: Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma

CALGB 140503    Phase III Randomized Trial of Lobectomy v. Sublobar Resection for Small (< 2 cm) Peripheral Non-Small Cell Lung Cancer

Keywords: Small (< 2 cm) Peripheral Non-Small Cell Lung Cancer

ACOSOG Z4033    A Pilot Study of Radiofrequency Ablation in High-Risk Patients with Stage 1A Non-Small Cell Lung Cancer

Keywords: Stage 1A Non-Small Cell Lung Cancer

H3E-MC-JMHD    Randomized, Open-Label, Phase III Study of Pemetrexed plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab v. Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer

Keywords: Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer

H3E-MC-JMIG    Phase III Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed versus Etoposide, Cisplatin, and Radiotherapy followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectabe, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other than Predominantly Squamous Cell Histology

Keywords: Patients with Unresectabe, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other than Predominantly Squamous Cell Histology

RTOG 0436    A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are Treated without Surgery

Keywords: Patients with Esophageal Cancer who are Treated without Surgery

 

 

Last Review Date: Nov. 18, 2009

Online Editor(s): Richard Petre

e-Newsletters

Monthly articles about the health topics of your choice!

Sign Up Today Sign Up Today

Log In to My Froedtert Log In to My Froedtert

Related Information
Quick Links
© 2009 Froedtert & The Medical College of Wisconsin
9200 West Wisconsin Avenue
Milwaukee, WI 53226